Doctor Describes RFID Implant Experience in New England Journal of Medicine Article
Aug. 4, 2005 -- VeriChip Corp., a provider of implantable and wearable RFID identification and security solutions, announced that the July 28, 2005, edition of the New England Journal of Medicine contains an article about the VeriChip by John Halamka, M.D., chief information officer of both Harvard Medical School and of Boston-based CareGroup Healthcare System. Halamka is also an emergency physician at Beth Israel Deaconess Medical Center, Boston, a CareGroup hospital and an affiliate of Harvard Medical School.
In the article, entitled "Straight from the Shoulder," Halamka discusses his experience of being implanted with the VeriChip, the only FDA-cleared, human-implantable RFID microchip, and his reasons for doing so.
VeriChip announced earlier this year that Beth Israel Deaconess Medical Center in Boston had agreed to implement VeriChip technology in its Emergency Department for clinical use. On Jan. 21, 2005, the company announced Halamka's decision to be implanted with a VeriChip and assess the technology.
VeriChip is a subsidiary of Applied Digital, a provider of identification and security technology for people, their assets, and their environments. The company provides the only FDA-cleared, human-implantable RFID microchip and active RFID tag with skin-sensing capabilities.
It also provides products for infant protection, wander prevention, and asset tracking, as well as for implantable health records applications.